Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-15-015140)

Filing Details

Accession Number:: 0001209191-15-015140
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2015-02-18 14:01:59
Reporting Period:: 2015-02-13

Filing Date:: 2015-02-18
Accepted Time:: 2015-02-18 14:01:59
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1044378	Biocept Inc	BIOC	Services-Medical Laboratories (8071)	330757995

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1024004	F David Hale	C/O Biocept, Inc. 5810 Nancy Ridge Drive #150 San Diego CA 92121	Chairman	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2015-02-13	40,000	$1.25	94,570	No	4	P	Indirect	By LLC

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By LLC

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Warrant to Purchase Common Stock	Acquisiton	2015-02-13	40,000	$0.00	40,000	$1.56

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
40,000	2015-02-13	2020-02-13	No	4	P	Indirect

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	10,204	Direct

Footnotes

Shares were purchased from the issuer in a unit offering, with each unit consisting of one share of Common Stock and one warrant to purchase one share of Common Stock for $1.25 per unit.